Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2019

Open Access 01-12-2019 | Ampicillin | Research article

The activity of commercial antimicrobials, and essential oils and ethanolic extracts of Olea europaea on Streptococcus agalactiae isolated from pregnant women

Authors: Munyaradzi Mukesi, Benson C. Iweriebor, Larry C. Obi, Uchechukwu U. Nwodo, Sylvester R. Moyo, Anthony I. Okoh

Published in: BMC Complementary Medicine and Therapies | Issue 1/2019

Login to get access

Abstract

Background

Streptococcus agalactiae also known as Group B Streptococcus (GBS) is a major cause of disease in pregnant women and new born babies where it causes early and late onset disease characterised by sepsis, pneumonia and meningitis. Ten to 37 % of pregnant women in the world are colonised with GBS while intrapartum antibiotic prophylaxis has led to significant reduction in early onset disease. The increase in drug resistant microorganisms has become a major threat. Development of vaccines is still in progress so there is need for new and safer alternatives to treatment.

Methods

Benzyl penicillin, Ampicillin, Cefotaxime, Ceftriaxone, Levofloxacin, Erythromycin, Clindamycin, Linezolid, Vancomycin, Tetracycline and Cotrimoxazole, Olea europaea leaf extracts and essential oil were tested against GBS isolates from South Africa and Namibia.

Results

The isolates showed 100% sensitivity to benzyl penicillin, ampicillin, ceftriaxone, levofloxacin, linezolid, vancomycin, O. europaea leaf extracts and essential oils. Only one isolate (0.6%) was resistant to cefotaxime and 23.4 and 10.4% were resistant to clindamycin and erythromycin respectively.

Conclusion

GBS isolates showed sensitivity to O. europaea extracts at low minimum inhibitory concentrations. Β lactams are still the drugs of choice for treatment of GBS disease but O. europaea extracts potent as an alternative source of antimicrobials.
Literature
1.
go back to reference Biasi-Garbin RP, Otaguiri ES, Morey AT, da Silva MF, Morquette AEB, Lancheros CAC, et al. Effect of eugenol against Streptococcus agalactiae and synergistic interaction with biologically produced silver nanoparticles. Evidence Based Complementary and Alternative Medicine. 2015. https://doi.org/10.1155/2015/861497. Biasi-Garbin RP, Otaguiri ES, Morey AT, da Silva MF, Morquette AEB, Lancheros CAC, et al. Effect of eugenol against Streptococcus agalactiae and synergistic interaction with biologically produced silver nanoparticles. Evidence Based Complementary and Alternative Medicine. 2015. https://​doi.​org/​10.​1155/​2015/​861497.
4.
go back to reference Matani C, Trezzi M, Matteini A, Catalani C, Messeri D, Catalani C. Streptococcus agalactiae: prevalence of antimicrobial resistance in vaginal and rectal swabs in Italian pregnant women. Le Infezioni in Medicina. 2016;3:217–21. Matani C, Trezzi M, Matteini A, Catalani C, Messeri D, Catalani C. Streptococcus agalactiae: prevalence of antimicrobial resistance in vaginal and rectal swabs in Italian pregnant women. Le Infezioni in Medicina. 2016;3:217–21.
6.
go back to reference Ojdana D, Sacha P, Wieczorek P, Czaban S, Michalska A, Jaworowska J, et al. The occurrence of blaCTX-M, blaSHV, and blaTEM genes in extended-Spectrum β-lactamase-positive strains of Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in Poland. International Journal of Antibiotics. 2014. https://doi.org/10.1155/2014/935842. Ojdana D, Sacha P, Wieczorek P, Czaban S, Michalska A, Jaworowska J, et al. The occurrence of blaCTX-M, blaSHV, and blaTEM genes in extended-Spectrum β-lactamase-positive strains of Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in Poland. International Journal of Antibiotics. 2014. https://​doi.​org/​10.​1155/​2014/​935842.
7.
go back to reference Back EE, O’Grady EJ, Back JD. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital. Antimicrob Agents Chemother. 2011;56(2):739–42.CrossRef Back EE, O’Grady EJ, Back JD. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital. Antimicrob Agents Chemother. 2011;56(2):739–42.CrossRef
8.
go back to reference Maroyi A, Cheikhyoussef A. A comparative study of medicinal plants used in rural areas of Namibia and Zimbabwe. Indian J Tradit Knowl. 2014;14(3):401–6. Maroyi A, Cheikhyoussef A. A comparative study of medicinal plants used in rural areas of Namibia and Zimbabwe. Indian J Tradit Knowl. 2014;14(3):401–6.
10.
go back to reference Darsanaki RK, Aliabadi MA, Rokhi ML, Nourbakhsh M, Raeisi G. Antimicrobial activity of olive leaf aqueous extract. Ann Biol Res. 2012;3(8):4189–91. Darsanaki RK, Aliabadi MA, Rokhi ML, Nourbakhsh M, Raeisi G. Antimicrobial activity of olive leaf aqueous extract. Ann Biol Res. 2012;3(8):4189–91.
11.
go back to reference Elbaradie SMY, Mahmoud M, Farid M. Maternal and neonatal screening for group B streptococci by SCP B gene based PCR: a preliminary study. Indian J Med Microbiol. 2009;27(1):17–21.PubMed Elbaradie SMY, Mahmoud M, Farid M. Maternal and neonatal screening for group B streptococci by SCP B gene based PCR: a preliminary study. Indian J Med Microbiol. 2009;27(1):17–21.PubMed
12.
go back to reference Gray KJ, Bennett SL, French N, Phiri AJ, Graham SM. Invasive group B streptococcal infection in infants, Malawi. Emerg Infect Dis. 2007;13(2):223–9.CrossRef Gray KJ, Bennett SL, French N, Phiri AJ, Graham SM. Invasive group B streptococcal infection in infants, Malawi. Emerg Infect Dis. 2007;13(2):223–9.CrossRef
13.
go back to reference Gebremeskel TK, Zeleke TA, Mihret A, Tikue MD. Prevalence and antibiotic susceptibility pattern of Streptococcus agalactiae among pregnant women at Adigrat zonal hospital and Adigrat health center. J Gynecol Obstet. 2015;3(2):29–35.CrossRef Gebremeskel TK, Zeleke TA, Mihret A, Tikue MD. Prevalence and antibiotic susceptibility pattern of Streptococcus agalactiae among pregnant women at Adigrat zonal hospital and Adigrat health center. J Gynecol Obstet. 2015;3(2):29–35.CrossRef
14.
go back to reference Moyo SR, Maeland JA, Munemo ES. Susceptibility of Zimbabwean Streptococcus agalactiae (group B Streptococcus; GBS) isolates to four different antibiotics. Cent Afr J Med. 2001;47(9–10):226–9.PubMed Moyo SR, Maeland JA, Munemo ES. Susceptibility of Zimbabwean Streptococcus agalactiae (group B Streptococcus; GBS) isolates to four different antibiotics. Cent Afr J Med. 2001;47(9–10):226–9.PubMed
16.
go back to reference Ezeonu IM, Agbo MC. Incidence and anti-microbial resistance profile of group B Streptococcus (GBS) infection in pregnant women in Nsukka, Enugu State. Nigeria Academic J. 2014;8(1):91–5. Ezeonu IM, Agbo MC. Incidence and anti-microbial resistance profile of group B Streptococcus (GBS) infection in pregnant women in Nsukka, Enugu State. Nigeria Academic J. 2014;8(1):91–5.
17.
go back to reference Dutra VG, Alves VMN, Olendzki AN, Dias CAG, de Bastos AFA, et al. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect Dis. 2014;14:323.CrossRef Dutra VG, Alves VMN, Olendzki AN, Dias CAG, de Bastos AFA, et al. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect Dis. 2014;14:323.CrossRef
18.
go back to reference Al-Bahry SN, Mahmoud IY, Al-Musharafi SK. The Overuse of Tetracycline Compounds in Chickens and Its Impact on Human Health. 2013 4th International Conference on Food Engineering and Biotechnology IPCBEE vol.50, vol. 50. Singapore: IACSIT Press; 2013. p. 5. https://doi.org/10.7763/IPCBEE. Al-Bahry SN, Mahmoud IY, Al-Musharafi SK. The Overuse of Tetracycline Compounds in Chickens and Its Impact on Human Health. 2013 4th International Conference on Food Engineering and Biotechnology IPCBEE vol.50, vol. 50. Singapore: IACSIT Press; 2013. p. 5. https://​doi.​org/​10.​7763/​IPCBEE.
19.
go back to reference Mengist A, Kannan H, Abdissa A. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B Streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res Notes. 2016;9:351.CrossRef Mengist A, Kannan H, Abdissa A. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B Streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res Notes. 2016;9:351.CrossRef
20.
go back to reference Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of Bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis. 2000;31(1):170–6.CrossRef Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of Bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis. 2000;31(1):170–6.CrossRef
21.
go back to reference Crewe-Brown HH, Reyneke MP, Khoosal M, Becker PJ, Karstaedt AS. Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath hospital, Soweto, in the AIDS era. SAMJ. 2000;94 No. 6. Crewe-Brown HH, Reyneke MP, Khoosal M, Becker PJ, Karstaedt AS. Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath hospital, Soweto, in the AIDS era. SAMJ. 2000;94 No. 6.
22.
go back to reference Coutsoudis A, Coovadia HM, Kindra G. Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries. Bull World Health Organ. 2010;88:949–50.CrossRef Coutsoudis A, Coovadia HM, Kindra G. Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries. Bull World Health Organ. 2010;88:949–50.CrossRef
23.
go back to reference Marwa KJ, Mushi MF, Konje E, Alele PE, Kidola J, Mirambo MM. Resistance to Cotrimoxazole and other antimicrobials among isolates from HIV/AIDS and non-HIV/AIDS patients at Bugando medical Centre, Mwanza, Tanzania. AIDS Res Treat. 2015. https://doi.org/10.1155/2015/103874. Marwa KJ, Mushi MF, Konje E, Alele PE, Kidola J, Mirambo MM. Resistance to Cotrimoxazole and other antimicrobials among isolates from HIV/AIDS and non-HIV/AIDS patients at Bugando medical Centre, Mwanza, Tanzania. AIDS Res Treat. 2015. https://​doi.​org/​10.​1155/​2015/​103874.
24.
go back to reference Boukhebti H, Chaker AN, Lograda T, Ramdani M. Chemical and antimicrobial properties of essential oils of Olea europaea L. Int J Pharmacol Toxicol. 2015;5(1):42–6. Boukhebti H, Chaker AN, Lograda T, Ramdani M. Chemical and antimicrobial properties of essential oils of Olea europaea L. Int J Pharmacol Toxicol. 2015;5(1):42–6.
Metadata
Title
The activity of commercial antimicrobials, and essential oils and ethanolic extracts of Olea europaea on Streptococcus agalactiae isolated from pregnant women
Authors
Munyaradzi Mukesi
Benson C. Iweriebor
Larry C. Obi
Uchechukwu U. Nwodo
Sylvester R. Moyo
Anthony I. Okoh
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2019
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-019-2445-4

Other articles of this Issue 1/2019

BMC Complementary Medicine and Therapies 1/2019 Go to the issue